HIV and AIDS

The PrEP Communications Accelerator is a free interactive, digital resource that supports national governments, program implementers, and health practitioners to develop marketing and communications that drive demand for PrEP in sub-Saharan Africa. 

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial was launched in 2015 to test the comparative risk of HIV acquisition among women using one of the following three contraceptive methods: depo-medroxyprogesterone acetate intramuscular (DMPA-IM), also known as Depo-Provera, two-rod levonorgestrel sub-dermal implant (LNG-Implant), branded as Jadelle, and the copper intrauterine device (Copper-IUD). 

Nepal's health sector needs accurate, comprehensive and disaggregated data to gauge its performance, identify disparities between social groups and geographic areas, and plan future interventions. 

 The purpose of this guide is to facilitate effective and guided community discussion on the issues of cultural and traditional practices that contribute to the spread of HIV in the community, and to help Change Agents in the community to carry out prevention activities in ways that incorporate appropriate and culturally sensitive messages to achieve project objectives.

Pages